Advances in Influenza Treatment: Optimizing Outcomes in High-Risk Influenza Patients with Chronic Cardiometabolic Conditions |
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium: The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches |
- 1.50 CDE
- 1.25 ACPE Pharmacy
- 1.25 AMA PRA Category 1 Credit™
- 1.20 ANCC
- 1.25 Participation
|
Enduring |
|
$0.00 |
When COVID-19 Meets Interstitial Lung Disease: Implications for Acute and Long-Term Management |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Challenging the Status-Quo: Cardiorenal Protection with SGLT-2 Inhibitors in T2DM and Beyond—Expert Debate and Discussions |
- 2.25 ACPE Pharmacy
- 2.25 AMA PRA Category 1 Credit™
- 2.25 ANCC
- 2.25 Participation
|
Enduring |
|
$0.00 |
Vaccine-Preventable Diseases in the Age of COVID-19: How Can We Keep Them at Bay? |
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: Update on Antiplatelet and Antithrombotic Therapy in the Cardiometabolic Patient |
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 CDE
- 0.75 Participation
|
Enduring |
|
$0.00 |
2020 CMHC Annual On Demand - Evolving Paradigms in Cardiometabolic Care: Disparities & Advancements |
- 15.00 CDE
- 15.00 ACPE Pharmacy
- 15.00 AMA PRA Category 1 Credit™
- 15.00 ANCC
- 15.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium: ABC Access To Care Initiative: Overcoming Disparities and Gaps in the Diagnosis and Treatment of Familial Hypercholesterolemia |
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 CDE
- 1.50 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium: Tackling Diabetic Kidney Disease Progression: Challenges, Advances, and Novel Approaches |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 CDE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - Preventing Adverse Cardiovascular and Limb Events in High-Risk Cardiometabolic Patients with Peripheral Artery Disease: Recent... |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: What BMI Should Be Used for Metabolic Surgery? |
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 CDE
- 0.50 Participation
|
Enduring |
|
$0.00 |
The Nexus of COPD, Cardiovascular Disease, and COVID-19: Key Strategies To Optimize Outcomes |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - The Challenge of Chronic Hyperkalemia in Cardiometabolic Patients: Advances and Opportunities |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
CMHC Masterclass On Demand: Who Best to Stem the Cardiometabolic Tsunami |
- 6.75 CDE
- 6.75 ACPE Pharmacy
- 6.75 AMA PRA Category 1 Credit™
- 6.75 ANCC
- 6.75 Participation
|
Enduring |
|
$0.00 |